Nicholas Borcherding, MD, PhD

Assistant Professor of Pathology and Immunology, Washington University at St. Louis
Biography

Mentor: Weizhou Zhang, MD
 

Awarded MD, PhD in Cancer Biology and Medicine in Spring 2020

Thesis: 

Big Data Analytics and Cancer Biology: Lessons in Taking Science from the Processor to the Patient  

 

Other positions:

  • 2023-24 Head of Computational Biology at Omniscope
  • 2022-23 Consulting Senior Computational Biologist at Santa Ana Bio, Inc. 
  • 2022-23 Postdoctoral Researcher, Barnes-Jewish Hospital
  • 2020-23 Clinical Pathology Resident, Washington University in St. Louis

Awards:

  • 2023 Emerging Generation Award from the American Society for Clinical Investigation (ASCI)
  • 2018 Hancher-Finkbine Award, University of Iowa
  • 2017-20 NIH-NCI Fellowship F30 CA206255 "The role of paracrine WNT5A/RYK in ErbB2-driven tumorigenesis"

Selected Publications:

Pubmed

  1. Borcherding N, Brestoff JR.  The power and potential of mitochondria transfer. Nature. 2023 Nov; 623(7986): 283-291.
  2. Borcherding N, Kusner D, Kolb R, Xie Q, Li W, et al. Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating Cells. Cancer Res. 2015 May 15;75(10):1972-82. 
  3. Borcherding N, Bormann N, Kusner D, Kolb R, Zhang W. Transcriptome analysis of basal and luminal tumor-initiating cells in ErbB2-driven breast cancer. Genom Data. 2015 Jun 1;4:119-122. 
  4. Borcherding N, Voigt AP, Liu V, Link BK, Zhang W, Jabbari A. Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression. 
    Clin Cancer Res. 2019 May 15; 25(10): 2996-3005. 
Nick Borcherding
Education
BS, Iowa State University; MD and PhD, University of Iowa